Increase of Serum Ferritin as a Marker for the rRVR under antiviral Triple Therapy with Telaprevir, PEG-Interferon alfa-2a and Ribavirin for chronic Hepatitis C

被引：0
|
作者：
Zopf, S. [1 ]
Janisch, F. [2 ]
Siebler, J. [3 ]
Neurath, M. [1 ]
Janisch, H. [4 ]
机构：
[1] Univ Klinikum Erlangen, Med Klin, Erlangen, Germany
[2] Univ Rostock, D-18055 Rostock, Germany
[3] Univ Klinikum Erlangen, Med Klin 1, Erlangen, Germany
[4] Praxisklin Gastroenterol Hepatol, Erlangen, Germany
来源：
INTERNIST | 2013年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [1] Increase of Serum Ferritin Levels During HCV Triple Therapy With Telaprevir, PEG-Interferon ALPHA-2A and Ribavirin Predicts Rrvr
    Zopf, Steffen
    Janisch, Florian
    Siebler, Juergen
    Neurath, Markus F.
    Janisch, Hans-Dieter
    GASTROENTEROLOGY, 2013, 144 (05) : S980 - S980
  • [2] CHOLESTEROL LEVELS AND PRESENCE OF DIABETES PREDICT EARLY VIROLOGICAL RESPONSE TO TRIPLE THERAPY WITH TELAPREVIR, PEG-INTERFERON alfa-2a 180 μg AND RIBAVIRIN IN CHRONIC HEPATITIS C
    Jaeckel, E.
    Zehnter, E.
    John, C.
    Heyne, R.
    Teuber, G.
    Schiffelholz, W.
    Christensen, S.
    Antoni, C.
    Pape, S.
    Roessle, M.
    Loehr, H.
    Stoll, S.
    Alshuth, U.
    Hueppe, D.
    Mauss, S.
    Manns, M. P.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S340 - S340
  • [3] Telaprevir resistance mutations in patients with hepatitis C who relapsed after sequential therapy with telaprevir, peg-interferon alfa 2A and ribavirin
    Forestier, Nicole
    Susser, Simone
    Welker, Martin W.
    Weegink, Christine J.
    Reesink, Hendrik W.
    Zeuzem, Stefan
    Sarrazin, Christoph
    HEPATOLOGY, 2007, 46 (04) : 255A - 256A
  • [4] Characterization of Hepatitis C Patients who fail to Achieve Sustained Virologic Response with Triple Therapy (Peg-Interferon Alfa and Ribavirin with Boceprevir or Telaprevir)
    Cheetham, T. Craig
    Yuan, Yong
    Niu, Fang
    Kalsekar, Anupama
    Hechter, Rulin
    Chiang, Kevin
    Hay, Joel
    Nyberg, Lisa M.
    HEPATOLOGY, 2014, 60 : 938A - 938A
  • [5] Use of PEG-interferon alfa-2a plus ribavirin as treatment for chronic HCV hepatitis in a child cured of ALL
    Lo Nigro, L
    La Spina, M
    Mirabile, E
    Pisana, P
    Schilirò, G
    Guardo, P
    PEDIATRIC BLOOD & CANCER, 2004, 43 (02) : 185 - 185
  • [6] Sustained virological response of Peg-interferon alfa-2a plus ribavirin for chronic hepatitis C virus infection genotype IV
    Shiha, G.
    Abass, B.
    El-Shenawy, H.
    Zalata, K.
    LIVER INTERNATIONAL, 2006, 26 : 81 - 81
  • [7] PEG-Interferon alfa2b plus ribavirin treatment in chronic hepatitis C
    Müller, T
    MONATSSCHRIFT KINDERHEILKUNDE, 2005, 153 (12) : 1192 - 1192
  • [8] A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C
    Angelico, Mario
    Petrolati, Alessandra
    Lionetti, Raffaella
    Lenci, Ilaria
    Burra, Patrizia
    Donato, Maria Francesca
    Merli, Manuela
    Strazzabosco, Mario
    Tisone, Giuseppe
    JOURNAL OF HEPATOLOGY, 2007, 46 (06) : 1009 - 1017
  • [9] THE ROLE OF FERRITIN AS A RESPONSE MARKER FOR ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH PEGINTERFERON ALFA-2A (PEGIFN) AND RIBAVIRIN (RBV)
    Klass, Dietmar M.
    Zizer, Eugen
    Link, Ralph
    Heyne, Renate
    Lutz, Thomas
    Schmidt, Wolfgang
    Goesseringer, Roger
    Alshuth, Ulrich
    Mauss, Stefan
    Hueppe, Dietrich
    HEPATOLOGY, 2011, 54 : 868A - 868A
  • [10] Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C
    Lens, Sabela
    Calleja, Jose L.
    Campillo, Ana
    Carrion, Jose A.
    Broquetas, Teresa
    Perello, Christie
    de la Revilla, Juan
    Marino, Zoe
    Londono, Maria-Carlota
    Sanchez-Tapias, Jose M.
    Urbano-Ispizua, Alvaro
    Forns, Xavier
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (17) : 5421 - 5426
12345